A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT01813123
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
788
1
2
71
11.1

Study Details

Study Description

Brief Summary

This study is designed to develop and test a gender-specific, web-based drug abuse prevention program. Study participants will be adolescent girls aged 13 and 14 years who will complete all measures online. Randomly assigned girls will also interact online with a skills-based program and subsequent annual booster sessions.

The study's primary hypothesis is that rates of 30-day alcohol and drug use will be lower among girls assigned to receive the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: RealTeen
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
788 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls
Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Jul 1, 2017
Actual Study Completion Date :
Jan 30, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Experimental: Intervention

RealTeen

Behavioral: RealTeen
A web-based, gender-specific program intended improve girls' cognitive and behavioral skills. Each of the 9 sessions requires approximately 20 minutes. After initial intervention, girls will receive two annual booster sessions (i.e., a 20-minute review of previously learned material indexed to new age).

Outcome Measures

Primary Outcome Measures

  1. 30-day alcohol and drug use [Up to 3 years]

    Measures will ask girls to report, for the past 30 days, the number of: drinks of alcohol consumed, cigarettes smoked, puffs of marijuana, and times they consumed four or more drinks within 2 hours. Girls will also report past 30-day use of: inhalants, ecstasy, club drugs, prescription drugs for recreational use, heroin, and hallucinogens.

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 14 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • resident of USA

  • speaks English

  • have private computer with Internet

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Columbia University School of Social Work New York New York United States 10027

Sponsors and Collaborators

  • Columbia University
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Traci M Schwinn, PhD, Columbia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Traci M. Schwinn, Associate Research Scientist, Columbia University
ClinicalTrials.gov Identifier:
NCT01813123
Other Study ID Numbers:
  • AAAJ3409
  • R01DA031782
First Posted:
Mar 18, 2013
Last Update Posted:
Jun 27, 2019
Last Verified:
Jun 1, 2019
Keywords provided by Traci M. Schwinn, Associate Research Scientist, Columbia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 27, 2019